Nuformix (LSE:NFX) COGS-to-Revenue : 0.00 (As of Sep. 2022)

View and export this data going back to 2015. Start your Free Trial

What is Nuformix COGS-to-Revenue?

Nuformix's Cost of Goods Sold for the six months ended in Sep. 2022 was £0.00 Mil. Its Revenue for the six months ended in Sep. 2022 was £0.00 Mil.

Nuformix's COGS to Revenue for the six months ended in Sep. 2022 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Nuformix's Gross Margin % for the six months ended in Sep. 2022 was N/A%.

Nuformix COGS-to-Revenue Historical Data

The historical data trend for Nuformix's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuformix COGS-to-Revenue Chart

Nuformix Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

COGS-to-Revenue

Get a 7-Day Free Trial

13.60

0.88

0.62

0.32

0.04

Nuformix Semi-Annual Data
	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23
COGS-to-Revenue	Get a 7-Day Free Trial									-	0.04	-	-	-

Nuformix COGS-to-Revenue Calculation

Nuformix's COGS to Revenue for the fiscal year that ended in Mar. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.002	/	0.05
	=	0.04

Nuformix's COGS to Revenue for the quarter that ended in Sep. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Nuformix (LSE:NFX) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Nuformix's Gross Margin % for the six months ended in Sep. 2022 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Nuformix COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Nuformix's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Nuformix (LSE:NFX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (LSE:NFX) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

1RT:Germany

Address

60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR

Website

https://www.nuformix.com

Nuformix PLC is a pharmaceutical development company. It operates in the field of pharmaceutical development targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.